SCHEMBL2230517

SCHEMBL2230517

COc1cccc2c1N(CCCCBr)C(=O)CC2

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR7 P34969 3/20 0.47
MEN1 O00255 1/20 0.47
CYP1A2 P05177 1/20 0.47
HTR1A P08908 1/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
KMT2A Q03164 1/20 0.47
GRIN1 Q05586 1/20 0.47
GRIN2B Q13224 1/20 0.47
DRD2 P14416 3/20 0.44
DRD3 P35462 3/20 0.44
DRD4 P21917 2/20 0.44
DRD5 P21918 1/20 0.41
AADAT Q8N5Z0 1/20 0.40
SIGMAR1 Q99720 1/20 0.39
BRD4 O60885 1/20 0.39
CHRM1 P11229 2/20 0.38
CHRM2 P08172 1/20 0.38
CHRM4 P08173 1/20 0.38
CHRM5 P08912 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1764015 0.87 HTR7 (0.47) HTR7MEN1CYP1A2HTR1ACYP2C9
SCHEMBL8844887 0.86 HTR7 (0.48) HTR7MEN1CYP1A2HTR1ACYP2C9
SCHEMBL1764057 0.80 SIGMAR1 (0.58) HTR7MEN1CYP1A2HTR1ACYP2C9
SCHEMBL96857 0.76 AADAT (0.48) DRD2DRD3DRD4DRD5AADAT
SCHEMBL4236105 0.76 CHRM1 (0.53) GRIN1GRIN2BDRD2DRD3DRD4
SCHEMBL6441694 0.75 CHRM1 (0.68) HTR7MEN1CYP1A2HTR1ACYP2C9
SCHEMBL1764224 0.74 DRD2 (0.60) GRIN1GRIN2BDRD2DRD3DRD4
SCHEMBL9369725 0.72 DRD2 (0.50) HTR1ADRD2
SCHEMBL9025470 0.72 HRH1 (0.52) HTR7MEN1HTR1AKMT2AGRIN1
SCHEMBL5384961 0.72 DRD2 (0.59) GRIN1GRIN2BDRD2DRD3DRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1751116-B1 Pyrimidine compounds and use thereof in the treatment of central nervous system disorders ABBOTT GMBH & CO KG (DE) 2013-07-31 EP disclosed
EP-2361908-A1 Pyrimidine compounds useful for the treatment of CNS diseases Abbott GmbH & Co. KG (DE) 2011-08-31 EP disclosed
EP-1751116-A2 PYRIMIDINE COMPOUNDS AND USE THEREOF Abbott GmbH & Co. KG (DE) 2007-02-14 EP disclosed
WO-2005118558-A2 PYRIMIDINE COMPOUNDS AND USE THEREOF ABBOTT GMBH & CO. KG (DE) 2005-12-15 WO disclosed